FDA Approves Expanded Indication for Two Transcatheter Heart Valves for Patients at Intermediate Risk for Death or Complications Associated with Open-Heart Surgery

Be the first to comment

Leave a Reply

Your email address will not be published.


This site uses Akismet to reduce spam. Learn how your comment data is processed.